Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 9, 2018Clinical Gastroenterology and HepatologyOpen Access

Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis

View Full Paper
Ask AI
Bookmark
Share

Authors

SHStephen B. HanauerRPRemo PanaccioneSDSilvio Danese

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hanauer et al. (2018) studied this question.

synapsesocial.com/papers/6a7bfd3c0449e558d7c2c1dfhttps://doi.org/10.1016/j.cgh.2018.07.009
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Treatment of ulcerative colitis from the patient’s perspective: a survey of preferences and satisfaction with therapy2009 · 54 citations
  2. 2Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis1987 · 3,067 citations
  3. 3Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis2013 · 2,913 citations